Hospital de Sagunto-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2015

  1. The use of adalimumab, etanercept, golimumab and infliximab in rheumatic pathologies: Variation between label dosage and real-world use

    Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 15, Núm. 5, pp. 851-858